Doctors were shocked after the clinical trial of the cancer drug cured the disease in all participants
A new colorectal cancer drug has shocked researchers with its effectiveness against highly dangerous disease, after it has cured virtually every member of a clinical trial. Dostarlimab, a monoclonal antibody drug already approved to treat endometrial cancer in the UK, broke expectations in a trial at the Memorial Sloan Kettering Cancer Center in New York. …